通化东宝药业股份有限公司关于2020年员工持股计划股票出售完毕的公告

Group 1 - The company has completed the sale of all shares held under the 2020 employee stock ownership plan [1][7] - The employee stock ownership plan was approved by the company's board and shareholders in late 2020 [1][2] - The management committee for the employee stock ownership plan was established to oversee daily management and represent shareholders [2] Group 2 - The first unlocking period of the employee stock ownership plan allowed for the release of 364.40 million shares, representing 40% of the total shares held [4] - The second unlocking period allowed for the release of 273.30 million shares, representing 30% of the total shares held [4] - The plan was terminated early in January 2024, with 273.30 million shares remaining unallocated [5][6] Group 3 - The shares were sold through a centralized bidding process in the secondary market, adhering to trading regulations [7] - The management committee will complete asset liquidation and distribution following the sale of the shares [7]